C-2801X, a new cephamycin-type antibiotic II. Isolation and characterization

Area of Science:

• Microbiology
• Natural Product Chemistry
• Pharmacology

Background:

• Streptomyces species are prolific producers of diverse bioactive compounds.
• Cephamycins are a class of beta-lactam antibiotics with potent antimicrobial activity.
• The emergence of antibiotic-resistant bacteria necessitates the discovery of new antimicrobial agents.

Purpose of the Study:

• To identify and characterize novel antibiotics produced by newly discovered Streptomyces species.
• To evaluate the antibacterial spectrum and potential of the isolated compounds.
• To determine if the new antibiotic represents a novel class or a variation of existing ones.

Main Methods:

• Isolation and cultivation of new Streptomyces species (S. heteromorphus and S. panayensis).
• Separation of antibiotics using column chromatography on Amberlite XAD-2.
• Purification of the new antibiotic C-2801X as its mono-sodium salt.
• Determination of molecular formula (C25H28N3O12SNa) and assessment of physicochemical properties.
• Evaluation of antibacterial activity against Gram-positive and Gram-negative bacteria.

Main Results:

• Two new species, Streptomyces heteromorphus and S. panayensis, were identified.
• A novel antibiotic, C-2801X, was co-produced with cephamycins A and B.
• C-2801X demonstrated significant antibacterial activity against both Gram-positive and Gram-negative bacteria.
• Activity was observed even against bacterial strains resistant to cephamycins A and B.
• Physicochemical and biological properties suggest C-2801X is a new cephamycin-type antibiotic.

Conclusions:

• The discovery of S. heteromorphus and S. panayensis expands the known diversity of antibiotic-producing Streptomyces.
• C-2801X represents a promising new antibiotic candidate with a broad spectrum of activity.
• Its efficacy against resistant strains highlights its potential therapeutic value in combating infections caused by drug-resistant pathogens.